National Alliance Research Department Continues Expansion
Corey Davis to Launch Specialty Pharmaceutical Coverage
NEW YORK--(BUSINESS WIRE)--National Alliance Capital Markets (NACL), the institutional broker-dealer arm of National Alliance Securities, LLC, today is proud to announce the addition of Corey Davis, Ph.D. as a senior analyst in the equity research department soon to be covering Specialty Pharmaceuticals. The Texas-based firm, which has an office in New York City, has been carving out a niche equity business based on its technology, media and telecommunications equities research offering. Robert Weinstein, managing director and head of the equities desk added “expanding into healthcare is part of our carefully crafted plan to execute on our steady growth strategy. Corey brings with him a wealth of information and experience that will add tremendous value to our clients.”
“His 16+ years of experience is a valued asset that we as a firm hope to expand upon in the coming months and years.”
Before joining National Alliance, Corey spent 16 years covering the same Specialty Pharmaceuticals space, most recently at Jefferies & Co. He also covered the space at Natixis Bleichroeder and JP Morgan and its predecessor firms. “Corey’s experience in Specialty Pharma brings a unique and novel product offering in an era when balanced seasoned equity analysts are hard to come by,” said Mark Salter, Managing Partner of National Alliance. “His 16+ years of experience is a valued asset that we as a firm hope to expand upon in the coming months and years.”
About National Alliance
National Alliance Securities, LLC, founded in 2003, is a full-service institutional broker-dealer with offices in New York, Boston, Austin, Houston, Dallas, Sarasota, San Francisco, Red Bank, Newark and Stamford.